Natural history of fetal trisomy 13 after prenatal diagnosis

Sinead C Barry1, Colin A Walsh, Annette L Burke

  • 1Department of Obstetrics and Gynecology, Galway University Hospital, National University of Ireland Galway, Newcastle Road, Galway, Ireland.

Insights

Prenatal diagnosis of trisomy 13 with pregnancy continuation shows high rates of intrauterine death (46.2%) and early neonatal mortality (93%). Survival beyond six weeks is rare, highlighting the need for accurate parental counseling.

Area of Science:

  • Perinatology
  • Genetics
  • Neonatal Medicine

Background:

  • Limited data exist on the natural history and outcomes of fetal trisomy 13 diagnosed prenatally.
  • Parental decisions for pregnancy continuation necessitate clear prognostic information.

Purpose of the Study:

  • To evaluate fetal and neonatal outcomes in pregnancies with prenatal trisomy 13 diagnosis where parents opted to continue the pregnancy.
  • To provide data for improved parental counseling regarding trisomy 13.

Main Methods:

  • Retrospective analysis of obstetric and neonatal outcome data.
  • Inclusion of cases diagnosed at two referral Fetal Medicine Centers.
  • Examination of 45 cases of trisomy 13 diagnosed prenatally.

Main Results:

  • Of 45 cases, 26 (56%) continued the pregnancy. Intrauterine death occurred in 46.2% of cases.
  • Live birth rate was 53.8%. Neonatal death within the first day occurred in 78.6% of live births.
  • Overall early neonatal mortality was 93%; no survival beyond six weeks was observed.

Conclusions:

  • Prenatal diagnosis of trisomy 13 with continued pregnancy has a poor fetal and neonatal outcome.
  • The study provides crucial data for parental counseling on intrauterine death risks.
  • Observed survival outcomes are worse than previously suggested by postnatal follow-up studies.

Related Concept Videos

Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
176.2K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
39.0K
Karyotyping01:17

Karyotyping

Overview
48.9K
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
67.4K
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.1K